Goldman Thinks R1 RCM Inc. (RCM) Is A Long-Term AI Stock Set To Rally Eventually
R1 RCM Inc. (RCM): An Under The Radar AI Stock You Should Pay Attention To
R1 RCM Edges Higher After European Commission Clears Towerbrook, CD&R Deal
Truist Financial Maintains R1 RCM(RCM.US) With Hold Rating
Truist Financial analyst Jailendra Singh maintains $R1 RCM(RCM.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 35.0% and a total average return of -13.8% over
Truist Financial Releases a Hold Rating on R1 RCM (RCM)
EU Clears Joint Purchase of US Revenue Cycle Management Company R1 RCM
J. Michael Cline, Fandango Co-Founder Who Changed the Moviegoing Experience, Dies at 64 -- Journal Report
Cantor Fitzgerald Reiterates Neutral on R1 RCM, Maintains $14.3 Price Target
Hold Rating Affirmed for R1 RCM Amidst Revenue Forecast Adjustment and Pending Acquisition
R1 RCM Is Maintained at Hold by Truist Securities
In-Depth Examination Of 10 Analyst Recommendations For R1 RCM
Hold Rating on R1 RCM Amidst Cyberattack Impact and Revenue Delays
Earnings Call: R1 RCM Inc. Navigates Cyberattack, Posts Solid Q2 Results
Truist Adjusts Price Target on R1 RCM to $14.30 From $16, Maintains Hold Rating
Earnings Call Summary | R1 RCM(RCM.US) Q2 2024 Earnings Conference
R1 RCM Inc. (RCM) Q2 2024 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY), R1 RCM (RCM) and Lumos Pharma (LUMO)
R1 RCM | 10-Q: Q2 2024 Earnings Report
R1 RCM GAAP EPS of -$0.02 Beats by $0.03, Revenue of $627.9M Misses by $5.2M
Express News | R1 RCM Inc: Due to Recently Proposed Deal, Co Not Providing Financial Guidance